EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients. (Q46717312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Tsutomu Nakamura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Toshiyuki Sakaeda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Noboru Okamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Akinobu Gotoh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Shuji Terao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Masahi Morioka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Kenji Tokui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hisato Tanaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mariko Yagi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Yoshihiro Nishimura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mitsuhiro Yokoyama

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Katsuhiko Okumura

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

22 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1757-1761

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue

7 January 2020

cites work

1 reference

12 December 2020

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

12 December 2020

Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?

1 reference

12 December 2020

Requirement for the von Hippel-Lindau tumor suppressor gene for functional epidermal growth factor receptor blockade by monoclonal antibody C225 in renal cell carcinoma

1 reference

12 December 2020

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

12 December 2020

Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

12 December 2020

Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer

1 reference

12 December 2020

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

Modulation of tumor growth and tumor induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 in renal cell carcinoma

1 reference

12 December 2020

Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma

1 reference

12 December 2020

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

12 December 2020

Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens

1 reference

12 December 2020

Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.

1 reference

12 December 2020

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

12 December 2020

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

1 reference

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

12 December 2020

Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

Predictive factors for epidermal growth factor receptor inhibitors--the bull's-eye hits the arrow

1 reference

12 December 2020

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

1 reference

12 December 2020

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

12 December 2020

Focus on kidney cancer

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma

1 reference

12 December 2020

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma

1 reference

12 December 2020

Targeting targeted therapy

1 reference

12 December 2020

ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor receptor-extracellular signal-regulated kinase pathway

1 reference

12 December 2020

Gefitinib--a novel targeted approach to treating cancer

1 reference

12 December 2020

Epidermal growth factor receptor content in human renal cell carcinomas

1 reference

12 December 2020

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

1 reference

12 December 2020

Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.

1 reference

12 December 2020

10.1007/S11095-005-7094-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16180134%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference